Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 22;13:757–766. doi: 10.2147/DDDT.S180836

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Li et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Comparison of T47D-WT-inoculated group and T47D-17β-HSD1-inoculated group when different levels of E1 are administered.

Notes: Vehicle (0 µg/kg/day) (A); low dose of E1 (0.1 µg/kg/day) (B); intermediate dose of E1 (0.5 µg/kg/day) (C); high dose of E1 (2.5 µg/kg/day) (D). When treated with the intermediate level of E1, tumor growth showed a significantly greater difference between the T47D-WT-inoculated group and T47D-17β-HSD1-inoculated group. Values are expressed as mean ± SD. *P<0.05; ***P<0.001; n=5 or 8.

Abbreviations: E1, estrone; NS, not significant.